Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: PM Johnson confirms England lockdown easing on May 17

Mon, 10th May 2021 18:55

(Alliance News) - People in England will be able to hug loved ones, dine in restaurants and go on holiday abroad from next week in a "considerable step on the road back to normality", Prime Minister Boris Johnson has confirmed.

The move to the next stage of the road map out of lockdown on May 17 came as the Covid-19 alert level in the UK was downgraded after a "consistent" fall in cases, hospital admissions and deaths.

The prime minister set out a new approach to tackling the virus, giving people greater responsibility for their own choices on whether to observe social distancing measures with friends and family.

"Today we are taking a step towards that moment when we learn to live responsibly with Covid, when we cease eventually to rely on detailed Government edicts and make our own decisions," he said.

Confirmation that England would move to step three on the road map came from Johnson at a Downing Street press conference after a Cabinet meeting to sign off the change.

The prime minister said: "This unlocking amounts to a very considerable step on the road map to normality and I am confident that we will be able to go further."

The road map remained on track for the next stage on June 21 and Johnson promised that later this month the government would set out "what role there could be – if any – for certification and social distancing".

The government has been reviewing whether Covid status certification, recording whether people have had a vaccine or negative test result, could be used to help open up businesses and Johnson's comments could be a hint they are no longer a priority.

Johnson said the current data indicated that it might be possible to scrap the "one-metre plus" rule, something which would greatly increase flexibility for businesses to increase capacity.

From May 17:

– People will be able to meet outdoors in groups of up to 30.

– People will be able to meet indoors in groups of six, or two households.

– Pubs and restaurants will be able to serve customers indoors, although they will be limited to table service.

– Cinemas, museums, theatres and concert halls will be allowed to reopen although there will be capacity limits on large events.

– The "stay in the UK" restriction will lift and people will be able to travel to "green list" countries, such as Portugal although they are still being advised not to go to destinations on the amber list.

– Up to 30 people will be allowed at weddings, although dancing will still not be allowed, and the cap on the number of mourners attending funerals will be lifted, in line with the safe capacity of the venue.

– Secondary school pupils will no longer be told to wear face masks in class and communal areas.

– University students will return to campus for in-person lectures.

The easing of restrictions came after the UK's senior medics said the Covid-19 alert level should be lowered from "level 4" to "level 3", meaning that while the epidemic is in general circulation, transmission is no longer deemed to be high or rising exponentially.

But England's chief medical officer Professor Chris Whitty urged particular caution around the Indian variant which has been detected in increasing numbers in the UK.

From a low level "it has gone up very sharply" he said, warning that it was possibly more transmissible than the Kent variant which swept across the UK in the winter.

But "at this point in time our view is that it is less likely to be able to escape vaccination than some of the other variants".

Up to May 5, some 520 confirmed or probable cases of the Indian strain had been identified, an increase of 318 in a week.

The latest figures showed that up to May 9, 35.5 million people have had a first dose of vaccine, a rise of 100,626 on the previous day, while 17.9 million of those have now also had a second doses, an increase of 187,171.

A further four people died within 28 days of testing positive for Covid-19 as of Monday, bringing the UK total by that measure to 127,609.

The figures on the government dashboard showed none of the new deaths reported on Monday were in England, Scotland or Northern Ireland but there is often a lag in data following a weekend.

The government also said that, as of 0900 BST on Monday, there had been a further 2,357 lab-confirmed cases in the UK, bringing the total to 4.44 million.

Meanwhile, BioNTech SE has said its Covid-19 vaccine with Pfizer SE does not need to be tweaked to tackle variants of the virus currently in circulation.

But it said that it has a strategy to "address these variants should the need arise in the future".

In further positive news, analysis by Public Health England found a single dose of the AstraZeneca PLC vaccine reduces the risk of death with Covid-19 by approximately 80% – and two doses of Pfizer cut it by 97%.

By David Hughes, PA Political Editor

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.